| Type |
Details |
Score |
| Allele |
| Name: |
transgene insertion WT13, Joseph R Nevins |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion WT21, Joseph R Nevins |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion TA14, Joseph R Nevins |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion TA41, Joseph R Nevins |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion TA39, Joseph R Nevins |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Kairbaan M Hodivala-Dilke |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transient receptor potential cation channel, subfamily C, member 5; targeted mutation 2.1, David E Clapham |
| Allele Type: |
Targeted |
| Attribute String: |
Epitope tag |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Shu-Bing Qian |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
collagen, type I, alpha 1; targeted mutation 20, The Netherlands Cancer Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
collagen, type I, alpha 1; targeted mutation 21, The Netherlands Cancer Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transmembrane channel-like gene family 2; endonuclease-mediated mutation 1, Ulrich Muller |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Epitope tag |
|
•
•
•
•
•
|
| Allele |
| Name: |
gamma-aminobutyric acid type A receptor subunit alpha 2; targeted mutation 1, Stephen J Moss |
| Allele Type: |
Targeted |
| Attribute String: |
Epitope tag, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 331; endonuclease-mediated mutation 1, Francois Spitz |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Modified regulatory region |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 307328; endonuclease-mediated mutation 1, Francois Spitz |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Modified regulatory region |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 357; targeted mutation 1.1, Jussi Taipale |
| Allele Type: |
Targeted |
| Attribute String: |
Modified regulatory region |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, transgenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Volkhard Lindner |
| Allele Type: |
Transgenic |
| Attribute String: |
Conditional ready, Epitope tag, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Sana Yokoi |
| Allele Type: |
Transgenic |
| Attribute String: |
Epitope tag, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 5, Sana Yokoi |
| Allele Type: |
Transgenic |
| Attribute String: |
Epitope tag, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 9, Sana Yokoi |
| Allele Type: |
Transgenic |
| Attribute String: |
Epitope tag, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 13, Sana Yokoi |
| Allele Type: |
Transgenic |
| Attribute String: |
Epitope tag, Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hurlin PJ |
| Year: |
1999 |
| Journal: |
EMBO J |
| Title: |
Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. |
| Volume: |
18 |
| Issue: |
24 |
| Pages: |
7019-28 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hundley JE |
| Year: |
1997 |
| Journal: |
Cancer Res |
| Title: |
Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. |
| Volume: |
57 |
| Issue: |
4 |
| Pages: |
600-3 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Santoni-Rugiu E |
| Year: |
1996 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. |
| Volume: |
93 |
| Issue: |
18 |
| Pages: |
9577-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mouse Genome Informatics Scientific Curators |
| Year: |
2022 |
|
| Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Regulatory Build. |
|
|
|
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
94
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
75
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lafita-Navarro MC |
| Year: |
2016 |
| Journal: |
Oncotarget |
| Title: |
MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis. |
| Volume: |
7 |
| Issue: |
43 |
| Pages: |
69536-69548 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
MXD1, also known as MAD, binds Max to form a repressive transcription factor. It antagonizes MYC transcriptional activity by competing for MAX []. It has also been shown to regulate rRNA synthesis []. |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
104
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
187
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
84
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
157
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
142
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
52
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Davis-Smyth T |
| Year: |
1996 |
| Journal: |
J Biol Chem |
| Title: |
The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators. |
| Volume: |
271 |
| Issue: |
49 |
| Pages: |
31679-87 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Duncan R |
| Year: |
1994 |
| Journal: |
Genes Dev |
| Title: |
A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. |
| Volume: |
8 |
| Issue: |
4 |
| Pages: |
465-80 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Duan J |
| Year: |
2017 |
| Journal: |
PLoS One |
| Title: |
Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma. |
| Volume: |
12 |
| Issue: |
1 |
| Pages: |
e0169852 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gherzi R |
| Year: |
2014 |
| Journal: |
Semin Cell Dev Biol |
| Title: |
KSRP controls pleiotropic cellular functions. |
| Volume: |
34 |
|
| Pages: |
2-8 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Cell division cycle-associated protein 7 (CDCA7/JPO1) is a transcription regulator whose expression is activated by c-Myc and by E2F1 []. CDCA7 can associate with Myc in a phosphorylation-dependent manner. CDCA7 phosphorylation by AKT leads to loss of its association with Myc []. This interaction affects Myc-dependent apoptosis and transformation [, , ]. CDCA7 has also been identified as a Notch target involved in hematopoietic stem cell emergence []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents a domain found in the C terminus of Far upstream element-binding protein 1/2 (FUBP1/2) []. FUBP1 regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter [, ]. FUBP2, also known as KSRP (K homology-type splicing regulatory protein), is an single-strand-RNA binding protein that integrate different levels of gene expression and is required for proper immune response, lipid metabolism, cell fate decisions, and tissue regeneration []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shimizu E |
| Year: |
1996 |
| Journal: |
Gene |
| Title: |
Expression, regulation and polymorphism of the mxi1 genes. |
| Volume: |
176 |
| Issue: |
1-2 |
| Pages: |
45-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tanaskovic N |
| Year: |
2022 |
| Journal: |
Life Sci Alliance |
| Title: |
Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis. |
| Volume: |
5 |
| Issue: |
8 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baudino TA |
| Year: |
2003 |
| Journal: |
Mol Cell |
| Title: |
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. |
| Volume: |
11 |
| Issue: |
4 |
| Pages: |
905-14 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maura F |
| Year: |
2024 |
| Journal: |
Nat Commun |
| Title: |
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans. |
| Volume: |
15 |
| Issue: |
1 |
| Pages: |
3844 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Calvo A |
| Year: |
2008 |
| Journal: |
Oncogene |
| Title: |
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. |
| Volume: |
27 |
| Issue: |
40 |
| Pages: |
5373-84 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liefke R |
| Year: |
2016 |
| Journal: |
Mol Cell |
| Title: |
EPOP Interacts with Elongin BC and USP7 to Modulate the Chromatin Landscape. |
| Volume: |
64 |
| Issue: |
4 |
| Pages: |
659-672 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chung B |
| Year: |
2015 |
| Journal: |
Diabetologia |
| Title: |
The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice. |
| Volume: |
58 |
| Issue: |
10 |
| Pages: |
2403-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lavenu A |
| Year: |
1996 |
| Journal: |
Genomics |
| Title: |
Genomic structure and precise mapping of a thymic regulatory region on mouse chromosome 17 revealed by a c-myc transgene insertion. |
| Volume: |
34 |
| Issue: |
3 |
| Pages: |
381-8 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, transgenic, congenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Prasad VS |
| Year: |
1997 |
| Journal: |
Mol Carcinog |
| Title: |
Upregulation of endogenous p53 and induction of in vivo apoptosis in B-lineage lymphomas of E(mu)-myc transgenic mice by deregulated c-myc transgene. |
| Volume: |
18 |
| Issue: |
2 |
| Pages: |
66-77 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bric A |
| Year: |
2009 |
| Journal: |
Cancer Cell |
| Title: |
Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. |
| Volume: |
16 |
| Issue: |
4 |
| Pages: |
324-35 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grandjean CL |
| Year: |
2021 |
| Journal: |
Sci Adv |
| Title: |
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis. |
| Volume: |
7 |
| Issue: |
8 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shah MY |
| Year: |
2010 |
| Journal: |
Cancer Res |
| Title: |
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. |
| Volume: |
70 |
| Issue: |
14 |
| Pages: |
5840-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grima-Reyes M |
| Year: |
2022 |
| Journal: |
Sci Adv |
| Title: |
Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression. |
| Volume: |
8 |
| Issue: |
27 |
| Pages: |
eabn6491 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiche J |
| Year: |
2019 |
| Journal: |
Cell Metab |
| Title: |
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors. |
| Volume: |
29 |
| Issue: |
6 |
| Pages: |
1243-1257.e10 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bywater MJ |
| Year: |
2012 |
| Journal: |
Cancer Cell |
| Title: |
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. |
| Volume: |
22 |
| Issue: |
1 |
| Pages: |
51-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mori S |
| Year: |
2008 |
| Journal: |
Cancer Res |
| Title: |
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma. |
| Volume: |
68 |
| Issue: |
20 |
| Pages: |
8525-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Repellin CE |
| Year: |
2010 |
| Journal: |
PLoS One |
| Title: |
Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus. |
| Volume: |
5 |
| Issue: |
2 |
| Pages: |
e9092 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Aubrey BJ |
| Year: |
2015 |
| Journal: |
Cell Rep |
| Title: |
An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. |
| Volume: |
10 |
| Issue: |
8 |
| Pages: |
1422-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiche J |
| Year: |
2015 |
| Journal: |
Leukemia |
| Title: |
GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α. |
| Volume: |
29 |
| Issue: |
5 |
| Pages: |
1163-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Newbold A |
| Year: |
2014 |
| Journal: |
Oncogene |
| Title: |
The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma. |
| Volume: |
33 |
| Issue: |
47 |
| Pages: |
5415-23 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bénéteau M |
| Year: |
2012 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response. |
| Volume: |
109 |
| Issue: |
49 |
| Pages: |
20071-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Carter MJ |
| Year: |
2016 |
| Journal: |
Cell Death Differ |
| Title: |
BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma. |
| Volume: |
23 |
| Issue: |
2 |
| Pages: |
303-12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu H |
| Year: |
2022 |
| Journal: |
Cell Host Microbe |
| Title: |
Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis. |
| Volume: |
30 |
| Issue: |
8 |
| Pages: |
1139-1150.e7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shen YJ |
| Year: |
2015 |
| Journal: |
Cell Rep |
| Title: |
Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells. |
| Volume: |
11 |
| Issue: |
3 |
| Pages: |
460-73 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Thürmer M |
| Year: |
2022 |
| Journal: |
Nat Commun |
| Title: |
PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
2982 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mikkers H |
| Year: |
2002 |
| Journal: |
Oncogene |
| Title: |
Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice. |
| Volume: |
21 |
| Issue: |
43 |
| Pages: |
6559-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lykken JM |
| Year: |
2016 |
| Journal: |
Blood |
| Title: |
Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms. |
| Volume: |
127 |
| Issue: |
15 |
| Pages: |
1886-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meacham CE |
| Year: |
2009 |
| Journal: |
Nat Genet |
| Title: |
In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. |
| Volume: |
41 |
| Issue: |
10 |
| Pages: |
1133-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin CJ |
| Year: |
2008 |
| Journal: |
Cancer Res |
| Title: |
c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. |
| Volume: |
68 |
| Issue: |
13 |
| Pages: |
5326-34 |
|
•
•
•
•
•
|
| Allele |
| Name: |
hypoxanthine phosphoribosyltransferase 1; targeted mutation 6, Peter J Detloff |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
hypoxanthine phosphoribosyltransferase 1; targeted mutation 7, Peter J Detloff |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Unni AM |
| Year: |
2008 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. |
| Volume: |
105 |
| Issue: |
5 |
| Pages: |
1686-91 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 159, Ralph L Brinster |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
axin 1; targeted mutation 1, Frank Costantini |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
bone morphogenetic protein 7; targeted mutation 3, Elizabeth J Robertson |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
retinitis pigmentosa 1 (human); targeted mutation 1, Eric A Pierce |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
tripartite motif-containing 63; targeted mutation 1.1, Velocigene |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
polycystin 1, transient receptor potential channel interacting; targeted mutation 3.2, Alessandra Boletta |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion TA32, Franklin Costantini |
| Allele Type: |
Transgenic |
| Attribute String: |
Epitope tag, Inducible, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Nancy C Andrews |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Hubert Schorle |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, congenic, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yagi T |
| Year: |
2011 |
| Journal: |
Hum Mol Genet |
| Title: |
N88S seipin mutant transgenic mice develop features of seipinopathy/BSCL2-related motor neuron disease via endoplasmic reticulum stress. |
| Volume: |
20 |
| Issue: |
19 |
| Pages: |
3831-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ito D |
| Year: |
2012 |
| Journal: |
Hum Mol Genet |
| Title: |
Characterization of inclusion bodies with cytoprotective properties formed by seipinopathy-linked mutant seipin. |
| Volume: |
21 |
| Issue: |
3 |
| Pages: |
635-46 |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 13, Klaus Rajewsky |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 21; targeted mutation 1, Jussi Taipale |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 2, Stefan Rose-John |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
dynein axonemal assembly factor 6, retrotransposed; targeted mutation 1.1, Hiroshi Hamada |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 2, Kairbaan M Hodivala-Dilke |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 3, Kairbaan M Hodivala-Dilke |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 6, Kairbaan M Hodivala-Dilke |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 38; targeted mutation 1.1, Adolfo A Ferrando |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Modified regulatory region, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
regulatory region 38; targeted mutation 1.2, Adolfo A Ferrando |
| Allele Type: |
Targeted |
| Attribute String: |
Modified regulatory region, Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Charles Bieberich |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|